• Home
  • Oleksandr Topachevskyi
Oleksandr Topachevskyi

Oleksandr Topachevskyi
Digital Health Outcomes

PG Dip, Health Economics

About

38
Publications
2,674
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
144
Citations
Additional affiliations
January 2013 - October 2014
Digital Health Outcomes. http://digitalho.com/
Position
  • Founder/Health Economist

Publications

Publications (38)
Article
Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system. Access to the pharmaceutical market covers main areas of stages, including the health technology assessment (HTA). The aim of the wor...
Article
Full-text available
Background: Increasingly, multi-criteria decision analysis has gained importance as a method by which to assess the value of orphan drugs. However, very little attention has been given to the weight (relative preferences) of the individual criteria used in a framework. Aims: This study sought to gain an understanding of the preferential weights tha...
Article
Full-text available
ESTIMATION OF SUPPLY SIDE COST EFFECTIVENESS THRESHOLD IN UKRAINE: PERSPECTIVE USE IN HEALTH CARE DECISION-MAKING Topachevskyi O1, Piniazhko O1, Lebega O2 , Oleshchuk O3 1Member of the National EML Committee, Kyiv, Ukraine 2Technical SAFEMED Advisor 3Head of the National EML Committee, Kyiv, Ukraine OBJECTIVE Estimate supply side cost effective...
Article
Full-text available
Background: Many countries struggle with the prioritisation of introducing new vaccines because of budget limitations and lack of focus on public health goals. A model has been developed that defines how specific health goals can be optimised through immunisation within vaccination budget constraints. Methods: Japan, as a country example, could...
Conference Paper
OBJECTIVES: To understand the key functional differences between conventional cost-effectiveness Excel and web based model types. METHODS: An online survey consisting 18 end users and 5 model owners (n=23) was conducted. Respondents were asked to rate key criteria of both model types on a scale from 0 to 10. Model types were compared with the follo...
Conference Paper
OBJECTIVES: To inform decision makers who seek extension of Universal Mass Vaccination (UMV) about the most optimal allocation of funds across multiple preventative interventions or vaccines. To account for decision makers preferences using MCDA. METHODS: A multi cohort markov model was developed to assess clinical and economic consequences of vacc...
Conference Paper
Various online services such as Socialbakers, Keyhole, Gnip offer tools to analyze, fetch and collect data from social media. This data is often presented in a form of interactive web based dashboards, displaying various trends: number of posts, mentions, shares, likes over time. Facebook and Twitter have an API to access data on social media profi...
Article
Full-text available
Objectives To compare the cost-effectiveness of a universal mass vaccination (UMV) program with a 2 + 1 schedule of a 10-valent pneumococcal polysaccharide nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) against two strategies: 1) a no-vaccination strategy and 2) a pneumococcal 13-valent conjugate vaccine (PCV13) 2 + 1 stra...
Conference Paper
Objectives� The model aims to determine the optimal allocation of financial resources amongst various paediatric vaccines accounting for changes in budget and availability of new vaccines over time. This approach aims to inform decision makers who are seeking to extend their national immunisation programmes about the optimal mix of vaccines and seq...
Article
Full-text available
The clinical and economic burden associated with invasive and non-invasive pneumococcal and non-typeable Haemophilus influenzae (NTHi) diseases is substantial in the Latin America and Caribbean region, where pneumococcal vaccines have only been introduced to a few countries. This study analyzed the cost-effectiveness and cost utility of three diffe...
Article
Full-text available
Background Pneumococcal universal vaccination in Hong Kong was introduced in 2009.Objectives We assessed the health and economic impact of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PCV-10) compared with the current 13-valent pneumococcal conjugate vaccine (PCV-13) recommended for Hong Kong in 2011, p...
Conference Paper
OBJECTIVES: To compare the clinical and economic burden of community acquired pneumonia (CAP) with invasive pneumococcal diseases (IPD) in children less than 10 years of age, based on cost-effectiveness studies from 7 countries. METHODS: The clinical and economic burden of IPD and CAP hospitalisations in children less than 10 years of age over 1 ye...
Article
Full-text available
Background Streptococcus pneumoniae infections, which place a considerable burden on healthcare resources, can be reduced in a cost-effective manner using a 7-valent pneumococcal conjugate vaccine (PCV-7). We compare the cost effectiveness of a 13-valent PCV (PCV-13) and a 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjuga...
Article
Full-text available
We evaluated national rotavirus (RV) immunization programme costs to estimate how resulting changes in morbidity and mortality will influence government fiscal accounts over time. The assumption was that increased childhood survival in vaccinated cohorts leads to increased numbers of children consuming government resource, and an increased number o...

Network

Cited By

Projects

Project (1)